Choose a Year - 2007 Grant Recipients



2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2007 GRANT RECIPIENTS

2007 Senior Research Award

Leif Bergsagel, M.D.
Mayo Clinic, Arizona
"The Role of NFkB Pathway Mutations in MM"

Bjarne Bogen, Ph.D.
University of Oslo
"Toward MM Immunotherapy by Adoptive Transfer of Idiotype-specific T Cells"

Ruben Carrasco, M.D.
Dana-Farber Cancer Institute
"Genetic Screen to Identify Wnt Target Genes to Treat Myeloma"

Selina Chen-Kiang, Ph.D.
Weill Cornell University
"Cell Cycle Based Combination Therapy for MM"

Lionel Coignet, Ph.D.
Roswell Park Cancer Institute
"Validation of an Anti-JAG2 MAb for Treatment of MM"

Teru Hideshima, M.D.
Dana-Farber Cancer Institute
"Delineation of Differential Role of Canonical and Non-Canonical NFkB Pathways"

Shaji Kumar, M.D.
Mayo Clinic, Rochester
"Targeting Vascular Endothelial Growth Factor for Treatment of Myeloma"

Yulia Nefedova, Ph.D.
H. Lee Moffitt Cancer Center
"Therapeutic Targeting of Notch and bcl-2/bcl-xl in MM"

Erik Nelson, Ph.D.
Dana-Farber Cancer Institute
"Evaluation of Novel STAT3 Inhibitors in MM"

Michele Pagano, M.D.
New York University
"The Role of SCF Ubiquitin Ligases in MM"

Aaron Schimmer, M.D., Ph.D.
University Health Network
"Mechanism and Efficacy of Cyproheptadine as a Novel Anti-Myeloma Agent"

Megan Sykes, M.D.
Massachusetts General Hospital
"Stem Cell Rejection to Induce Anti-Tumor Immunity"

Yang Yang, M.D., Ph.D.
University of Alabama, Birmingham
"Novel Combination Therapies for MM"


2007 Animal Development Model Awards

Preet Chaudhary, M.D., Ph.D.
University of Pittsburgh
"A Transgenic Model of Multiple Myeloma"

Yaoqi Wang, Ph.D.
Dana Farber Cancer Institute
"Refinement of the XBP-1 mouse model of multiple myeloma"

Marxa Figueiredo, Ph.D.
University of California, Los Angeles
"Flexible, Regulated Transgenic Model to Examine Role of EZH2 In Myeloma"


2007 Research Fellow Award


Matthew Drake, M.D., Ph.D.
Mayo Clinic, Rochester
"Multiple Myeloma and Bone: Understanding the Destruction"

Igor Entin, Ph.D.
University of Arkansas for Medical Sciences
"Osteoblast and their Mesenchymal Progenitors in Myeloma"

Francesca Fiore, M.D.
University of Turin, Italy
"Tryptophan Metabolism in the Immune Dysregulation of Multiple Myeloma"

Jonathan Keats, Ph.D.
Mayo Clinic, Arizona
"Identification of Therapeutic Targets in the Non-Canonical NF-kB Pathway"

Juntao Luo, Ph.D.
University of California, Davis
"Novel Polymeric Targeting Nanocarrier for the Treatment of Multiple Myeloma"

Sridevi Ponduru, M.D., PhD.
Dana-Farber Cancer Institute
"Forward Chemical Genetic Approach to Protein Catabolism in Multiple Myeloma"

Toshiki Saito, M.D., Ph.D.
Massachusetts General Hospital
"Mechanism of Anti-Tumor Effects Induced by Allogeneic Donor-Cell Rejection"

James Stewart, Ph.D.
University of Arkansas for Medical Sciences
"Investigating CDH2 Function in Myeloma Plasma Cells and Myeloma Stem Cells"

Attaya Suvannasankha, M.D.
Indiana University
"The Role of c-FLIP in Multiple Myeloma"

Rodger Tiedemann, M.D., Ph.D.
Mayo Clinic, Arizona
"Characterizing Lethal and Drug-Sensitizing Kinome Targets in Myeloma"

Xiangao Huang, Ph.D.
Weill Medical College of Cornell University
"Novel Cdk4/6 Inhibitor Combination Therapy"


2007 Compound Validation Award


Attaya Suvannasankha, M.D.
"From laboratory to clinic; Dimethylaminoparthenolide (DMAPT) in Myeloma"


2007 Validation of Novel Combinations Award


Steven Grant, M.D.
"A Combination Strategy Targeting the Bcl-2 Family in Multiple Myeloma"

Karin Vanderkerken, Ph.D."Combining IGF-1R and HDAC inhibitors in MM models in vitro and in vivo"